News & Analysis as of

Pharmaceutical Industry › Governor Newsom

Benesch

AI Reporter - June 2025

Benesch on

The FDA began integration of generative AI across all its centers, a project that should be completed by the end of June. Newly appointed chief AI officer, Jeremy Walsh, and Office of Strategic Programs at CDER, Sridhar...more

Husch Blackwell LLP

California Enacts First-in-Nation Pharmacy Medication Error Reporting Law

Husch Blackwell LLP on

On October 8, 2023, Governor Gavin Newsom signed Assembly Bill 1286 (AB 1286), a sweeping pharmacy measure with several components aimed at promoting patient safety. Chief among AB 1286’s mandates is a new law requiring that...more

McDermott Will & Schulte

California Enacts PBM Anti-Discrimination Law

McDermott Will & Schulte on

On October 7, 2023, California Governor Gavin Newsom signed Senate Bill 786 (SB 786) into law, prohibiting pharmacy benefit managers (PBMs) from discriminating against covered entities participating in the 340B Program....more

Goodwin

Insulin Updates: March 2023

Goodwin on

On March 1, Eli Lilly was the first to announce U.S. list price reductions of 70% for its most commonly prescribed insulins and an expansion of its Insulin Value Program that caps patient out-of-pocket costs at $35 or less...more

Goodwin

Year in Review: Top Biosimilars-Related Regulatory Developments of 2022

Goodwin on

As 2022 comes to a close, we review Big Molecule Watch’s top five biosimilar regulatory developments of the year...more

Goodwin

CA Gov. Newsom Announces Budget Approval for Biosimilar Insulin Initiative

Goodwin on

On Thursday, July 7, 2022, California Governor Gavin Newsom announced that the most recent state budget, signed last week, includes a $100 million allotment for California to “contract to make [its] own insulin at a cheaper...more

BCLP

Implications of CCPA and CPRA on Clinical Trial Data

BCLP on

Given the recent updates to CCPA, and the possible approval of California Privacy Rights Act (CPRA) which is on the November 3 ballot, it is increasingly likely that personal information collected in the course of clinical...more

Hogan Lovells

California Governor vetoes bill to establish the Genetic Information Privacy Act

Hogan Lovells on

California’s “Genetic Information Privacy Act” (SB 980), vetoed on September 25, 2020 by Governor Gavin Newsom, would have established obligations for direct-to-consumer (“DTC”) genetic testing companies and others that...more

Patrick Malone & Associates P.C. | DC Injury...

California, Big Blues, and hospitals join the attack on sky-high drug prices

Patrick Malone & Associates P.C. | DC Injury... on

Big Pharma, with its relentless price gouging, may finally have poked in the eye the wrong people. But even as patients wait to see if hospitals, and now states and insurers, can beat down skyrocketing drug prices, isn’t it...more

9 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide